688505 复旦张江
已收盘 09-30 15:00:00
资讯
新帖
简况
复旦张江(01349)上涨5.6%,报2.45元/股
金融界 · 10-02 10:40
复旦张江(01349)上涨5.6%,报2.45元/股
复旦张江09月30日遭主力抛售1679万元 环比增加1947.56%
市场透视 · 09-30 15:18
复旦张江09月30日遭主力抛售1679万元 环比增加1947.56%
复旦张江(01349)出现大手卖出120万股,成交价$2.16,涉资259.2万
阿斯达克财经 · 09-27
复旦张江(01349)出现大手卖出120万股,成交价$2.16,涉资259.2万
复旦张江(01349)股价上升8.163%,现价港币$2.12
阿斯达克财经 · 09-27
复旦张江(01349)股价上升8.163%,现价港币$2.12
复旦张江09月27日遭主力抛售82万元 环比增加127.78%
市场透视 · 09-27
复旦张江09月27日遭主力抛售82万元 环比增加127.78%
复旦张江(01349)上涨5.1%,报2.06元/股
金融界 · 09-27
复旦张江(01349)上涨5.1%,报2.06元/股
复旦张江09月24日主力资金流出154万元 连续3日减仓
市场透视 · 09-24
复旦张江09月24日主力资金流出154万元 连续3日减仓
复旦张江(01349)上涨5.08%,报1.86元/股
金融界 · 09-24
复旦张江(01349)上涨5.08%,报1.86元/股
复旦张江(01349)注射用海姆泊芬治疗鲜红斑痣美国II期临床试验完成首例受试者入组
智通财经 · 09-23
复旦张江(01349)注射用海姆泊芬治疗鲜红斑痣美国II期临床试验完成首例受试者入组
复旦张江(01349.HK)注射用海姆泊芬治疗鲜红斑痣美国临床首例受试者入组
阿斯达克财经 · 09-23
复旦张江(01349.HK)注射用海姆泊芬治疗鲜红斑痣美国临床首例受试者入组
复旦张江(688505.SH):注射用海姆泊芬治疗鲜红斑痣美国Ⅱ期临床试验完成首例受试者入组
智通财经 · 09-23
复旦张江(688505.SH):注射用海姆泊芬治疗鲜红斑痣美国Ⅱ期临床试验完成首例受试者入组
复旦张江09月23日遭主力抛售122万元 环比增加388.00%
市场透视 · 09-23
复旦张江09月23日遭主力抛售122万元 环比增加388.00%
Invesco Hong Kong Limited减持复旦张江(01349)36.4万股 每股作价约2.17港元
智通财经 · 09-20
Invesco Hong Kong Limited减持复旦张江(01349)36.4万股 每股作价约2.17港元
复旦张江09月18日遭主力抛售48万元 环比增加585.71%
市场透视 · 09-18
复旦张江09月18日遭主力抛售48万元 环比增加585.71%
复旦张江: 本集团主要从事生物医药的创新研究开发、生产制造和市场营销
证星董秘互动 · 09-06
复旦张江: 本集团主要从事生物医药的创新研究开发、生产制造和市场营销
复旦张江09月05日主力资金流入59万元 连续3日加仓
市场透视 · 09-05
复旦张江09月05日主力资金流入59万元 连续3日加仓
XD复旦张08月30日获主力加仓116万元 环比增加1557.14%
市场透视 · 08-30
XD复旦张08月30日获主力加仓116万元 环比增加1557.14%
复旦张江(688505.SH):注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌Ⅲ期临床试验完成首例受试者入组
智通财经 · 08-26
复旦张江(688505.SH):注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌Ⅲ期临床试验完成首例受试者入组
复旦张江(01349):注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌III期临床研究完成首例受试者入组
智通财经 · 08-26
复旦张江(01349):注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌III期临床研究完成首例受试者入组
复旦张江(01349.HK)用于治疗三阴性乳腺癌药物临床研究完成首例受试者入组
阿斯达克财经 · 08-26
复旦张江(01349.HK)用于治疗三阴性乳腺癌药物临床研究完成首例受试者入组
公司概况
公司名称:
上海复旦张江生物医药股份有限公司
所属行业:
医药制造业
上市日期:
2020-06-19
主营业务:
上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究开发、生产制造和市场营销。主要产品为盐酸氨酮戊酸外用散、注射用海姆泊芬、抗肿瘤药物长循环盐酸多柔比星脂质体注射液等。其业务主要包括在中国从事研究、开发及销售自行开发的生物医药知识、为客户提供合约制研究、制造及出售医疗产品,以及提供其他医疗服务。公司还通过其子公司从事医疗投资管理、健康产业管理、项目投资、资产管理、投资咨询、商务咨询、医疗咨询及企业战略咨询业务。
发行价格:
8.95
{"stockData":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":8.25,"timestamp":1727679600000,"preClose":7.28,"halted":0,"volume":18507255,"delay":0,"floatShares":711000000,"shares":1036999999,"eps":0.1068,"marketStatus":"已收盘","marketStatusCode":5,"change":0.97,"latestTime":"09-30 15:00:00","open":7.55,"high":8.47,"low":7.29,"amount":146000000,"amplitude":0.1621,"askPrice":8.26,"askSize":236,"bidPrice":8.25,"bidSize":102,"shortable":0,"etf":0,"ttmEps":0.1068,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1728351000000},"adr":0,"adjPreClose":7.28,"symbolType":"stock_kcb","openAndCloseTimeList":[[1727659800000,1727667000000],[1727672400000,1727679600000]],"highLimit":8.01,"lowLimit":6.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1036572100,"pbRate":3.63,"roa":"--","roe":"2.99%","epsLYR":0.11,"committee":-0.162,"marketValue":8552000000,"floatMarketCap":5862000000,"peRate":77.247193,"changeRate":0.1332,"turnoverRate":0.026,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-10-08。","afterMarket":{"amount":26292.75,"volume":3187,"close":8.25,"buyVolume":0,"sellVolume":2813,"time":1727681637153,"indexStatus":"已收盘 09-30 15:30:00","preClose":7.28}},"requestUrl":"/m/hq/s/688505/wiki","defaultTab":"wiki","newsList":[{"id":"2472356531","title":"复旦张江(01349)上涨5.6%,报2.45元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356531","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356531?lang=zh_cn&edition=full","pubTime":"2024-10-02 10:40","pubTimestamp":1727836844,"startTime":"0","endTime":"0","summary":"10月2日,复旦张江(01349)盘中上涨5.6%,截至10:40,报2.45元/股,成交157.91万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年中报,复旦张江营业总收入4.08亿元、净利润7047.31万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/02104043706977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01349","BK1191","688505","BK0239"],"gpt_icon":0},{"id":"2471982120","title":"复旦张江09月30日遭主力抛售1679万元 环比增加1947.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471982120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471982120?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:18","pubTimestamp":1727680719,"startTime":"0","endTime":"0","summary":"09月30日, 复旦张江股价涨13.32%,报收8.25元,成交金额1.46亿元,换手率2.60%,振幅16.21%,量比7.22。复旦张江今日主力资金净流出1679万元,连续3日净流出,上一交易日主力净流出82万元,今日环比增加1947.56%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为42.86%,平均跌幅为2.35%。该股近5个交易日上涨27.71%,主力资金累计净流出1856万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1769万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930153505958778c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930153505958778c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2470775754","title":"复旦张江(01349)出现大手卖出120万股,成交价$2.16,涉资259.2万","url":"https://stock-news.laohu8.com/highlight/detail?id=2470775754","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470775754?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:08","pubTimestamp":1727424480,"startTime":"0","endTime":"0","summary":"[大手成交]复旦张江(01349)在下午04:08出现大手卖出,成交量为120万,成交价为港币$2.16,涉资259.2万。至目前为止,股价升10.204%,今日最高价为$2.16,而最低价为$1.95,总成交量为951.4万股,总成交金额港币$1.961千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV24092710521/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0239","688505","BK1191","01349"],"gpt_icon":0},{"id":"2470773195","title":"复旦张江(01349)股价上升8.163%,现价港币$2.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2470773195","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470773195?lang=zh_cn&edition=full","pubTime":"2024-09-27 15:55","pubTimestamp":1727423700,"startTime":"0","endTime":"0","summary":"[上升股]复旦张江(01349) 股价在下午03:55比前收市价上升8.163%,现股价为港币$2.12。至目前为止,今日最高价为$2.12,而最低价为$1.95。总成交量为767.4万股,总成交金额为港币$1.565千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2409279810/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK0239","01349","688505"],"gpt_icon":0},{"id":"2470596778","title":"复旦张江09月27日遭主力抛售82万元 环比增加127.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470596778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470596778?lang=zh_cn&edition=full","pubTime":"2024-09-27 15:18","pubTimestamp":1727421490,"startTime":"0","endTime":"0","summary":"09月27日, 复旦张江股价涨4.60%,报收7.28元,成交金额2110万元,换手率0.41%,振幅3.30%,量比1.34。复旦张江今日主力资金净流出82万元,上一交易日主力净流出36万元,今日环比增加127.78%。该股近5个交易日上涨12.00%,主力资金累计净流出300万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出83万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409271529119581253b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409271529119581253b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2470467117","title":"复旦张江(01349)上涨5.1%,报2.06元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470467117","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470467117?lang=zh_cn&edition=full","pubTime":"2024-09-27 11:31","pubTimestamp":1727407910,"startTime":"0","endTime":"0","summary":"9月27日,复旦张江(01349)盘中上涨5.1%,截至11:31,报2.06元/股,成交800.15万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年中报,复旦张江营业总收入4.08亿元、净利润7047.31万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/27113143565334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01349","BK1191","BK0239","688505"],"gpt_icon":0},{"id":"2469453556","title":"复旦张江09月24日主力资金流出154万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2469453556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469453556?lang=zh_cn&edition=full","pubTime":"2024-09-24 15:19","pubTimestamp":1727162345,"startTime":"0","endTime":"0","summary":"09月24日, 复旦张江股价涨4.64%,报收6.76元,成交金额1820万元,换手率0.38%,振幅4.18%,量比2.11。复旦张江今日主力资金净流出154万元,连续3日净流出,上一交易日主力净流出122万元,今日环比增加26.23%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为45.00%,平均跌幅为2.35%。该股近5个交易日上涨2.11%,主力资金累计净流出327万元;近20日主力资金累计净流出69万元,其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409241534189f123947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409241534189f123947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2469369524","title":"复旦张江(01349)上涨5.08%,报1.86元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2469369524","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469369524?lang=zh_cn&edition=full","pubTime":"2024-09-24 13:44","pubTimestamp":1727156665,"startTime":"0","endTime":"0","summary":"9月24日,复旦张江(01349)盘中上涨5.08%,截至13:44,报1.86元/股,成交142.32万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。截至2024年中报,复旦张江营业总收入4.08亿元、净利润7047.31万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/24134443442114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01349","BK1191","688505","BK0239"],"gpt_icon":0},{"id":"2469719316","title":"复旦张江(01349)注射用海姆泊芬治疗鲜红斑痣美国II期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2469719316","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469719316?lang=zh_cn&edition=full","pubTime":"2024-09-23 17:44","pubTimestamp":1727084681,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江 发布公告,公司研发的用于治疗鲜红斑痣的注射用海姆泊芬美国注册项目II期临床试验于近日成功完成美国首例受试者入组。海姆泊芬为全球首个针对鲜红斑痣治疗的光动力药物,是集新药靶、新化合物和新适应症于一体的新药。作为国家1.1类新药,注射用海姆泊芬已于2017年正式于中国大陆地区上市销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1576","688505","03347","BK0239","BK1583","BK1141","01349"],"gpt_icon":0},{"id":"2469119318","title":"复旦张江(01349.HK)注射用海姆泊芬治疗鲜红斑痣美国临床首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2469119318","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469119318?lang=zh_cn&edition=full","pubTime":"2024-09-23 17:41","pubTimestamp":1727084460,"startTime":"0","endTime":"0","summary":"复旦张江(01349.HK) 公布,公司研发的用于治疗鲜红斑痣的注射用海姆泊芬美国注册项目II期临床试验于近日完成美国首例受试者入组。(ha/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190401142440189_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190401142440189_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1383155/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01349","BK1191","BK0239","688505"],"gpt_icon":0},{"id":"2469982821","title":"复旦张江(688505.SH):注射用海姆泊芬治疗鲜红斑痣美国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2469982821","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469982821?lang=zh_cn&edition=full","pubTime":"2024-09-23 17:23","pubTimestamp":1727083431,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(688505.SH)发布公告,公司研发的用于治疗鲜红斑痣的注射用海姆泊芬美国注册项目(即F0026项目)II期临床试验近日于美国成功完成首例受试者入组。海姆泊芬为全球首个针对鲜红斑痣治疗的光动力药物,是集新药靶、新化合物和新适应症于一体的新药。作为第二代光敏剂,海姆泊芬有着化合物结构稳定、光毒作用低等特点,其用于鲜红斑痣治疗被收入人民卫生出版社《皮肤性病学》(第九版)教科书中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1191","BK1576","BK1583","01349","688505","BK0239","03347"],"gpt_icon":0},{"id":"2469611811","title":"复旦张江09月23日遭主力抛售122万元 环比增加388.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469611811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469611811?lang=zh_cn&edition=full","pubTime":"2024-09-23 15:19","pubTimestamp":1727075977,"startTime":"0","endTime":"0","summary":"09月23日, 复旦张江股价跌0.62%,报收6.46元,成交金额1211万元,换手率0.26%,振幅4.15%,量比1.55。复旦张江今日主力资金净流出122万元,上一交易日主力净流出25万元,今日环比增加388.00%。该股近5个交易日下跌3.87%,主力资金累计净流出180万元;近20日主力资金累计净流出11万元,其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409231537349576edb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409231537349576edb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2468567640","title":"Invesco Hong Kong Limited减持复旦张江(01349)36.4万股 每股作价约2.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468567640","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468567640?lang=zh_cn&edition=full","pubTime":"2024-09-20 20:30","pubTimestamp":1726835453,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,8月5日,Invesco Hong Kong Limited减持复旦张江(01349)36.4万股,每股作价2.1664港元,总金额约为78.86万港元。减持后最新持股数目为1616万股,最新持股比例为4.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","01349","688505"],"gpt_icon":0},{"id":"2468379795","title":"复旦张江09月18日遭主力抛售48万元 环比增加585.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468379795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468379795?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:18","pubTimestamp":1726643903,"startTime":"0","endTime":"0","summary":"09月18日, 复旦张江股价跌1.51%,报收6.52元,成交金额759万元,换手率0.16%,振幅4.23%,量比0.89。复旦张江今日主力资金净流出48万元,上一交易日主力净流出7万元,今日环比增加585.71%。该股近5个交易日下跌1.66%,主力资金累计净流入57万元;近20日主力资金累计净流出332万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918152820956c44a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918152820956c44a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2465661436","title":"复旦张江: 本集团主要从事生物医药的创新研究开发、生产制造和市场营销","url":"https://stock-news.laohu8.com/highlight/detail?id=2465661436","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465661436?lang=zh_cn&edition=full","pubTime":"2024-09-06 18:04","pubTimestamp":1725617053,"startTime":"0","endTime":"0","summary":"证券之星消息,复旦张江09月06日在投资者关系平台上答复投资者关心的问题。本集团主要从事生物医药的创新研究开发、生产制造和市场营销。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090618065595e766cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090618065595e766cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161726","688505","399441","BK0239"],"gpt_icon":0},{"id":"2465751470","title":"复旦张江09月05日主力资金流入59万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2465751470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465751470?lang=zh_cn&edition=full","pubTime":"2024-09-05 15:18","pubTimestamp":1725520704,"startTime":"0","endTime":"0","summary":"09月05日, 复旦张江股价涨1.05%,报收6.74元,成交金额942万元,换手率0.20%,振幅1.95%,量比0.75。复旦张江今日主力资金净流入59万元,连续3日净流入,上一交易日主力净流入60万元,今日环比减少1.67%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为33.33%,平均涨幅为0.72%。该股近5个交易日上涨2.43%,主力资金累计净流入357万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入84万元,其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090515265395e41d9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090515265395e41d9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2463093782","title":"XD复旦张08月30日获主力加仓116万元 环比增加1557.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463093782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463093782?lang=zh_cn&edition=full","pubTime":"2024-08-30 15:19","pubTimestamp":1725002375,"startTime":"0","endTime":"0","summary":"08月30日, XD复旦张股价涨1.37%,报收6.67元,成交金额1401万元,换手率0.30%,振幅2.74%,量比1.32。XD复旦张今日主力资金净流入116万元,连续3日净流入,上一交易日主力净流入7万元,今日环比增加1557.14%。|08月30日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|阿莱德|6.36%|#|力源信息|6.27%|#|智微智能|6.16%|#|三六五网|6.01%|#|真视通|5.95%|#|兆日科技|5.85%|#|好上好|4.89%|#|天利科技|4.72%|#|星辉娱乐|4.63%|#|双乐股份|4.54%|XD复旦张所在的化学制药行业,今日主力净流入1.71亿元,行业排名42/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408301546439f683400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408301546439f683400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2462966598","title":"复旦张江(688505.SH):注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌Ⅲ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2462966598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462966598?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:12","pubTimestamp":1724663535,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江 发布公告,公司研发的注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌的药物Ⅲ期临床研究于近日完成首例受试者入组。该药物由针对人滋养层细胞表面糖蛋白抗原靶点的单克隆抗体与SN38偶联组成。Trop-2在人体正常组织中有不同水平的表达,但在如乳腺癌、肺癌、胃癌等多种肿瘤中的表达水平都会显著升高。该药物拟用于治疗晚期实体瘤,包括但不限于乳腺癌、尿路上皮癌、非小细胞肺癌、宫颈癌及胃癌等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01349","03347","BK1141","688505","BK1583","BK0239","BK1191","BK1576"],"gpt_icon":0},{"id":"2462966998","title":"复旦张江(01349):注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌III期临床研究完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2462966998","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462966998?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:11","pubTimestamp":1724663516,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江 发布公告,公司研发的注射用FDA018抗体偶联剂用于治疗三阴性乳腺癌的药物III期临床研究(该研究)于近日成功完成首例受试者入组。该药物拟用于治疗晚期实体瘤,包括但不限于乳腺癌、尿路上皮癌、非小细胞肺癌、宫颈癌及胃癌等。该药物III期临床试验为评价其在TNBC患者中的有效性、安全性、药代动力学特征和免疫原性的随机、对照临床试验。截至本公告刊发日,该研究已完成首例受试者入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","III","BK4134","BK0239","688505","01349"],"gpt_icon":0},{"id":"2462905966","title":"复旦张江(01349.HK)用于治疗三阴性乳腺癌药物临床研究完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2462905966","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462905966?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:10","pubTimestamp":1724663400,"startTime":"0","endTime":"0","summary":"复旦张江(01349.HK) 公布,研发的注射用FDA018抗体偶联剂,即抗Trop2抗体偶联SN38,用于治疗三阴性乳腺癌(TNBC)的药物III期临床研究于近日成功完成首例受试者入组。(ca/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191015154325179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191015154325179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1375269/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0239","688505","01349","BK1191"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-19","address":"上海市浦东新区张江高科技园区蔡伦路308号","stockEarnings":[{"period":"1week","weight":0.2771},{"period":"1month","weight":0.2369},{"period":"3month","weight":0.2813},{"period":"6month","weight":0.081},{"period":"1year","weight":-0.1924},{"period":"ytd","weight":-0.0935}],"companyName":"上海复旦张江生物医药股份有限公司","boardCode":"AI0027","perCapita":"36486股","boardName":"医药制造业","registeredCapital":"10365万元","compareEarnings":[{"period":"1week","weight":0.2138},{"period":"1month","weight":0.1739},{"period":"3month","weight":0.1133},{"period":"6month","weight":0.0871},{"period":"1year","weight":0.0727},{"period":"ytd","weight":0.1215}],"survey":" 上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究开发、生产制造和市场营销。主要产品为盐酸氨酮戊酸外用散、注射用海姆泊芬、抗肿瘤药物长循环盐酸多柔比星脂质体注射液等。其业务主要包括在中国从事研究、开发及销售自行开发的生物医药知识、为客户提供合约制研究、制造及出售医疗产品,以及提供其他医疗服务。公司还通过其子公司从事医疗投资管理、健康产业管理、项目投资、资产管理、投资咨询、商务咨询、医疗咨询及企业战略咨询业务。","serverTime":1727886636869,"listedPrice":8.95,"stockholders":"19475人(较上一季度减少6.03%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,688505,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}